Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-28

Clinical Trial Update: Clozapine-induced Hypersalivation - Feasibility Trial [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 feasibility trial investigating approaches to clozapine-induced hypersalivation (sialorrhea).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

Sponsor: Mersey Care NHS Trust | Conditions: Sialorrhea | Phase 1, Phase 2 | Status: COMPLETED